Search results for "Salvage"

showing 6 items of 126 documents

Neural conservation in skull base surgery

2002

Surgical treatment of lesions of the skull base carries significant risk to the functioning of the cerebral hemispheres, brainstem, and cranial nerves. This risk is due to both (1) problems associated with maintaining an adequate blood flow while exposing and removing the tumor and (2) direct or indirect trauma to the brain, perineural tissues, and cranial nerves. These risks may be reduced if information about possible implications of surgical maneuvers on the cerebral blood flow and on the function of the patient’s CNS and cranial nerves is available and can be monitored during surgery of the skull base. The use of EMG neuromonitoring for the facial nerve and of brainstem evoked response …

medicine.medical_specialtySkull Base NeoplasmsMonitoring Intraoperativemedicine.arteryEvoked Potentials Auditory Brain Stemotorhinolaryngologic diseasesmedicineHumansStrokeEvoked Response AudiometrySalvage TherapyElectromyographybusiness.industryCranial nervesBrainGeneral Medicinemedicine.diseaseFacial nerveSurgeryFacial NerveSkullmedicine.anatomical_structureOtorhinolaryngologyCerebral blood flowBrainstemInternal carotid arteryOtologic Surgical ProceduresbusinessOtolaryngologic Clinics of North America
researchProduct

Früh- und Spätergebnisse der perkutanen transluminalen Angioplastie (PTA) beim Diabetiker

1991

Results of 127 iliac and femoropopliteal transluminal angioplasties in 97 diabetic patients are presented. Patients who had undergone iliac (n = 70), femoral (n = 41), and popliteal (n = 16) angioplasties for stenoses up to 15 cm long were followed up for 6-60 months. In diabetic patients presenting with only claudication or adequate runoff, the 5-year iliac patency rate was 76% and the femoral patency rate was 60%; these results were comparable with those found in non-diabetic patients. For limb salvage, 3-year patency rates were 66% for iliac, 37% for femoral, and 37% for popliteal angioplasties, and 5-year patency rates were 29% for iliac, 7% for femoral, and 0% for popliteal angioplasti…

medicine.medical_specialtyVascular diseasebusiness.industryLimb salvageFemoral arterymedicine.diseasePeripheralSurgeryStenosismedicine.anatomical_structuremedicine.arteryDiabetes mellitusmedicineRadiology Nuclear Medicine and imagingmedicine.symptomClaudicationbusinessArteryRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
researchProduct

Do SLC7 Family Members Constitute the Salvage Pathway in the Therapy of Cystinosis?

2012

medicine.medical_specialtybusiness.industryEndocrinology Diabetes and MetabolismBioinformaticsmedicine.diseaseBiochemistrySurgeryEndocrinologyCystinosisGeneticsmedicinebusinessMolecular BiologyNucleotide salvageMolecular Genetics and Metabolism
researchProduct

Modulation of AraC by Fludarabine: Results of Salvage Therapy by AMLCG

2001

Fludarabine was shown to increase the intracellular formation of AraCTP during treatment with AraC both in vitro and in vivo and had significant activity in patients with advanced acute myeloid leukemia (AML) when used in combination with AraC in phase II studies. However, the efficacy of fludarabin as chemo-modulatior of the AraC metabolism has not yet been assessed in phase III studies. Based on the S-HAI salvage regimen comprizing high-dose AraC q 12 hours on days 1,2,8, and 9 and idarubicin on days 3,4,10, and 11, the German AML Cooperative Group initiated a prospective randomized comparison between fludarabine q 12 hours on days 1, 2, 8, and 9 in addition to S-HAI as compared with S-HA…

medicine.medical_specialtybusiness.industryNauseaSalvage therapyNeutropeniamedicine.diseaseGastroenterology3. Good healthFludarabine03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisInternal medicineBacteremiamedicineVomitingMucositisIdarubicinmedicine.symptombusiness030215 immunologymedicine.drug
researchProduct

Steroid and vasoactive treatment for acute deafness after attempted hearing preservation acoustic neuroma surgery.

2004

<i>Objective:</i> To investigate whether intravenous steroid and vasoactive therapy in the acute postoperative period improves hearing outcome in patients who develop acute deafness after attempted hearing preservation surgery for acoustic neuroma (AN) through a retrosigmoid or a middle cranial fossa approach. <i>Study Design and Setting:</i> Retrospective controlled study in a tertiary care center. Thirty-six patients who had developed acute deafness after hearing preservation surgery for treatment of an AN were reviewed. Preoperative AAOHNS hearing class was A in 2, B in 2 and D in 32 patients. Twenty-seven patients were treated with prednisolone, hydroxyethyl star…

medicine.medical_specialtymedicine.drug_classHearing lossmedicine.medical_treatmentPrednisoloneVasodilator AgentsAnti-Inflammatory AgentsAcoustic neuromaDeafnessHydroxyethyl Starch DerivativesPostoperative ComplicationsAcoustic neuroma surgeryVasoactiveotorhinolaryngologic diseasesmedicineEvoked Potentials Auditory Brain StemHumansIn patientPentoxifyllineRetrospective StudiesSalvage TherapyHearing preservationChemotherapybusiness.industryNeuroma Acousticmedicine.diseaseSurgeryOtorhinolaryngologyAnesthesiaAcute DiseaseInjections IntravenousCorticosteroidDrug Therapy Combinationmedicine.symptombusinessORL; journal for oto-rhino-laryngology and its related specialties
researchProduct

Hypofractionated postoperative helical tomotherapy in prostate cancer: a mono-institutional report of toxicity and clinical outcomes

2018

Francesco Cuccia,1,2 Gianluca Mortellaro,2 Vincenzo Serretta,3 Vito Valenti,1,2 Antonella Tripoli,1,2 Marina Gueci,1,2 Nicoletta Luca,1,2 Antonio Lo Casto,4 Giuseppe Ferrera2 1Radiation Oncology School, University of Palermo, Palermo, Italy; 2Radiation Oncology, ARNAS-Civico Hospital, Palermo, Italy; 3Section of Urology, Department of Surgical Oncological and Oral Science, University of Palermo, Palermo, Italy; 4Radiation Oncology School, Section of Radiological Sciences, DIBIMED, Università degli Studi di Palermo, Palermo, Italy Purpose: This is a mono-institutional study of acute and late toxicities and early biochemical control of a retrospective series of 75 prostate…

medicine.medical_specialtymedicine.medical_treatmentUrologyTomotherapy030218 nuclear medicine & medical imaging03 medical and health sciencesProstate cancer0302 clinical medicineadjuvantsalvagemedicineradiotherapyOriginal ResearchGenitourinary systembusiness.industryhypofractionationCommon Terminology Criteria for Adverse Eventsmedicine.diseaseRadiation therapyOncologyprostate neoplasmCancer Management and Research030220 oncology & carcinogenesisToxicityHormonal therapyProstate neoplasmbusinessCancer Management and Research
researchProduct